Trial Information

Summary: International Clinical Research Associates is seeking individuals with mild to moderate symptoms associated with Alzheimer’s disease.

Patients must be taking a stable dose of either, Aricept, Reminyl or Excelon for the last 12 weeks. Patient must also have a caregiver to participate in the study. This study involves 12 clinic visits over 21 weeks.

All diagnostic and laboratory evaluations are done at no cost to the subject and study medication is provided at no charge. Transportation costs during study participation will be reimbursed.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:46:21 AM